Thrive Bioscience
Thrive Bio is commercializing lab instruments to automate cell & stem cell culture & automate assays for drug discovery & research.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD22—33m (Dealroom.co estimates Aug 2015.)
Beverly Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.0m | Seed | ||
N/A | $2.2m | Debt | |
N/A | $7.2m | Series A | |
N/A | $5.6m | Convertible | |
N/A | $13.5m | Convertible | |
Total Funding | CAD41.3m |
Related Content
Recent News about Thrive Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.